Drug Delivery in Oncology and Immunotherapy

Oncology and immunotherapy demand precision-targeted drug delivery systems to maximize therapeutic index and minimize toxicity. Nanocarriers, antibody-drug conjugates, and polymer-drug conjugates are at the forefront of innovation. These platforms enable site-specific delivery, controlled release, and reduced off-target effects. Immunotherapeutic delivery methods are being refined for vaccines, cytokines, and immune checkpoint inhibitors. Personalized formulations and tumor microenvironment-targeted systems are reshaping cancer treatment by enhancing efficacy and patient survival while reducing adverse effects.

    Related Conference of Drug Delivery in Oncology and Immunotherapy

    September 14-15, 2026

    6th International Conference on Pharmaceutical Chemistry

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    December 14-15, 2026

    5th Global Summit on Pharmaceutical Research

    Paris, France
    January 26-27, 2027

    22nd Annual Meet on Pharmaceutical Sciences

    Paris, France
    February 15-16, 2027

    23rd Annual Congress on Pharmacology and Toxicology

    Paris, France
    April 08-09, 2027

    21st World Drug Delivery Summit

    Vienna, Austria
    April 27-28, 2027

    10th European Biopharma Congress

    Paris, France
    April 27-28, 2027

    19th World Drug Delivery Summit

    Paris, France

    Drug Delivery in Oncology and Immunotherapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in